Qingdao Haier Biomedical Co (SHSE:688139) Accounts Payable & Accrued Expense : ¥895 Mil (As of Mar. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Qingdao Haier Biomedical Co Accounts Payable & Accrued Expense?

Qingdao Haier Biomedical Co's quarterly accounts payable & accrued expense declined from Sep. 2023 (¥829 Mil) to Dec. 2023 (¥800 Mil) but then increased from Dec. 2023 (¥800 Mil) to Mar. 2024 (¥895 Mil).

Qingdao Haier Biomedical Co's annual accounts payable & accrued expense increased from Dec. 2021 (¥756 Mil) to Dec. 2022 (¥912 Mil) but then declined from Dec. 2022 (¥912 Mil) to Dec. 2023 (¥800 Mil).

Qingdao Haier Biomedical Co Accounts Payable & Accrued Expense Historical Data

The historical data trend for Qingdao Haier Biomedical Co's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Qingdao Haier Biomedical Co Accounts Payable & Accrued Expense Chart

Qingdao Haier Biomedical Co Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

517.80

764.77

755.83

912.04

800.33

Qingdao Haier Biomedical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															885.68	892.96	829.50	800.33	894.76

Qingdao Haier Biomedical Co Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Qingdao Haier Biomedical Co (SHSE:688139) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Qingdao Haier Biomedical Co Ltd (SHSE:688139) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.1 Haier Road, Branding Building, Qingdao, CHN, 266101

Website

http://www.haiermedical.com

Qingdao Haier Biomedical Co Ltd is engaged in designing, manufacturing, marketing and sales of low temperature storage equipment for biomedical samples. The company provides provides complete storage solutions for biological sample banks, blood safety, vaccine safety, medical supplies and reagent safety.

Executives

Zhang Jiang Tao	Core technical personnel
Liu Ji Yuan	Core technical personnel
Teng Pei Kun	Core technical personnel
Wang Guang Sheng	senior management
Gong Yi	Director
Huang Yan Li	senior management
Chen Hai Tao	Senior management, core technical personnel
Liu Zhan Jie	Directors, senior managers, core technical personn
Mo Rui Juan	senior management
Wang Wen Fu	Director

Qingdao Haier Biomedical Co (SHSE:688139) Headlines

No Headlines